Trials / Unknown
UnknownNCT01173081
The Use of Teriparatide as an Adjunctive Therapy for the Treatment of Jones Fractures
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 38 (estimated)
- Sponsor
- Ohio Orthopedic Center of Excellence · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This randomized, placebo-controlled study will evaluate the effectiveness of the adjunctive use of teriparatide for the healing of Jones fractures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Teriparatide | 20mcg once daily for 16 weeks or until study endpoint is achieved. |
| DRUG | Placebo | matching dose of 20mcg of placebo once daily for 16 weeks or until study endpoint is achieved |
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2014-04-01
- Completion
- 2014-04-01
- First posted
- 2010-07-30
- Last updated
- 2012-06-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01173081. Inclusion in this directory is not an endorsement.